Company Analysis

Estrella Immunopharma, Inc. (ESLA)

Nasdaq: ESLA · Biological Products, (No Diagnostic Substances) · Emeryville, CA · filing with the SEC since 2021
Grade4.0
◀ Past 2.7● Present 3.4▶ Future 5.4
7 est.

Filings

225 filings since 2017 beside 33 insider forms · and emerging growth company · read from EDGAR on Nov 13, 2026
Due next and emerging growth company
10-Q Quarterly report for the quarter ending Sep 30, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end. by Nov 14, 2026
10-K Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends. by Mar 31, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. The proxy statement was last filed May 27, 2026.

Filings a yearinsider forms included
4923102392025
202120222023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 5 times in the last 36 months, the newest Oct 29, 2026.Listing warning from its exchange (8-K item 3.01): 6 times in the last 36 months, the newest Sep 8, 2026.Auditor change (8-K item 4.01): 1 time in the last 36 months, the newest Feb 2, 2024.SEC letters: 8 in the last 36 months, the newest Jan 22, 2026.A late-filing notice, Form NT 10-Q, filed May 18, 2026.A late-filing notice, Form NT 10-Q, filed Nov 15, 2023.
Insider forms 33

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Oct 29, 2026 8-K items 5.02, 8.01, 9.01 Officer or director change; Other event · Current report Oct 25, 2026
Sep 8, 2026 8-K item 3.01 Listing warning from its exchange · Current report Sep 1, 2026
Aug 21, 2026 8-K item 3.01 Listing warning from its exchange · Current report Aug 17, 2026
Aug 14, 2026 SCHEDULE 13G/A Large holder update, amended
Aug 13, 2026 10-Q Quarterly report Jun 30, 2026
Jun 30, 2026 8-K item 5.07 Shareholder vote · Current report Jun 29, 2026
May 27, 2026 DEF 14A Proxy statement Jun 29, 2026
May 18, 2026 10-Q Quarterly report Mar 31, 2026
May 18, 2026 NT 10-Q Late quarterly report notice Mar 31, 2026
May 15, 2026 SCHEDULE 13G Large holder notice
Apr 30, 2026 10-K/A Annual report, amended Dec 31, 2025
Mar 18, 2026 10-K Annual report Dec 31, 2025
Feb 13, 2026 424B3 Shelf offering
Jan 23, 2026 EFFECT Registration effective
Jan 22, 2026 CORRESP Reply to the SEC
Jan 22, 2026 S-1/A Listing registration, amended
Jan 16, 2026 S-1/A Listing registration, amended
Jan 13, 2026 8-K item 3.01 Listing warning from its exchange · Current report Jan 7, 2026
Jan 6, 2026 8-K items 1.01, 3.02, 7.01, 9.01 Major agreement signed; Shares sold without registration; Investor disclosure (Regulation FD) · Current report Jan 5, 2026
Jan 6, 2026 424B5 Shelf offering
Dec 29, 2025 UPLOAD SEC comment letter
Dec 22, 2025 S-1 Listing registration
Dec 4, 2025 8-K items 8.01, 9.01 Other event · Current report
Nov 12, 2025 10-Q Quarterly report Sep 30, 2025
Nov 6, 2025 8-K items 8.01, 9.01 Other event · Current report Nov 3, 2025
Sep 29, 2025 8-K item 8.01 Other event · Current report Sep 23, 2025
Sep 26, 2025 8-K item 5.02 Officer or director change · Current report Sep 22, 2025
Aug 12, 2025 10-Q Quarterly report Jun 30, 2025
Aug 7, 2025 8-K item 3.01 Listing warning from its exchange · Current report Aug 1, 2025
Jun 5, 2025 8-K items 8.01, 9.01 Other event · Current report
Jun 3, 2025 8-K items 1.01, 3.02, 8.01, 9.01 Major agreement signed; Shares sold without registration; Other event · Current report May 30, 2025
May 29, 2025 8-K items 8.01, 9.01 Other event · Current report
May 14, 2025 10-Q Quarterly report Mar 31, 2025
May 2, 2025 8-K item 3.01 Listing warning from its exchange · Current report Apr 30, 2025
Mar 25, 2025 10-KT Annual report, transition period Dec 31, 2024
Feb 21, 2025 8-K items 8.01, 9.01 Other event · Current report
Feb 20, 2025 8-K items 8.01, 9.01 Other event · Current report Feb 19, 2025
Dec 23, 2024 S-8 Employee stock plan registration
Dec 19, 2024 EFFECT Registration effective
Dec 17, 2024 CORRESP Reply to the SEC
40 of 225 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton ESLA · research, not advice